This gives far more credibility in the medical & scientic community for MXC R&D into medications, with the end goal of licensing. It’s not going to bring revenue stat, but part of the process to bring this. If people don’t understand the need I suggest you look at TGA SAS & C pathway to understand what is happening now for Cannepil. I had a sticky beak at HL Pharma on the weekend & they have a licence to import & distribute Medical Cannabis & SAS C pathway drugs.
To see this on PBS would just be fantastic for Epilepsy sufferers, to be able to go to their local pharmacy & get what they need, instead of travelling hundreds of kms to a major trial site to collect their medicine on SAS from a hospital pharmacy. I see this as a big positive. Early stage biotech as I said in another post this morning. Even big Pharmas go through this being registered on TGA for high cost drugs via SAS prior to PBS on open label ph 3 trials . I would rank Cannepil in the lower to medium cost range at an estimate of A$800 a month. A positive ANN on credibility, which is much needed here after recent events. Not so much on the revue side of things. Cannepil will be good.
- Forums
- ASX - By Stock
- Ann: MXC launches CannaHub with RMIT and HUJ
This gives far more credibility in the medical & scientic...
-
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RGT (ASX) to my watchlist
(20min delay)
|
|||||
Last
35.0¢ |
Change
0.030(9.38%) |
Mkt cap ! $16.94M |
Open | High | Low | Value | Volume |
32.0¢ | 35.0¢ | 32.0¢ | $3.361K | 9.732K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 16739 | 35.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
35.5¢ | 8746 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1666 | 0.300 |
1 | 20000 | 0.250 |
1 | 2200 | 0.230 |
1 | 4545 | 0.220 |
1 | 4761 | 0.210 |
Price($) | Vol. | No. |
---|---|---|
0.355 | 8746 | 1 |
0.360 | 971 | 2 |
0.365 | 100 | 1 |
0.370 | 2000 | 1 |
0.400 | 1183 | 5 |
Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
Featured News
RGT (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online